Psyence Biomedical Statistics
Total Valuation
PBM has a market cap or net worth of $5.43 million. The enterprise value is $15.14 million.
Important Dates
The next estimated earnings date is Sunday, February 2, 2025, before market open.
| Earnings Date | Feb 2, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PBM has 3.03 million shares outstanding. The number of shares has increased by 30.34% in one year.
| Current Share Class | 3.03M |
| Shares Outstanding | 3.03M |
| Shares Change (YoY) | +30.34% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 4.67% |
| Float | 2.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.09
| Current Ratio | 0.09 |
| Quick Ratio | 0.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -51.98 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -126.35% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.44 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 2.90 |
| 200-Day Moving Average | 28.43 |
| Relative Strength Index (RSI) | 39.22 |
| Average Volume (20 Days) | 5,391,409 |
Short Selling Information
The latest short interest is 76,088, so 2.51% of the outstanding shares have been sold short.
| Short Interest | 76,088 |
| Short Previous Month | 137,684 |
| Short % of Shares Out | 2.51% |
| Short % of Float | 2.86% |
| Short Ratio (days to cover) | 0.71 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.75M |
| Pretax Income | -37.27M |
| Net Income | -51.16M |
| EBITDA | -2.75M |
| EBIT | -2.75M |
| Earnings Per Share (EPS) | -$588.74 |
Full Income StatementBalance Sheet
The company has $733,188 in cash and $10.45 million in debt, giving a net cash position of -$9.71 million or -$3.20 per share.
| Cash & Cash Equivalents | 733,188 |
| Total Debt | 10.45M |
| Net Cash | -9.71M |
| Net Cash Per Share | -$3.20 |
| Equity (Book Value) | -10.97M |
| Book Value Per Share | -61.46 |
| Working Capital | -10.98M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.95 million and capital expenditures -$5,727, giving a free cash flow of -$2.95 million.
| Operating Cash Flow | -2.95M |
| Capital Expenditures | -5,727 |
| Free Cash Flow | -2.95M |
| FCF Per Share | -$0.97 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |